Evidence map›Paper›PMID 26935937›Full record

ArticleBMC research notes2016

Persistent polyclonal binucleated B-cell lymphocytosis and MECOM gene amplification.

Edouard Cornet, Hossein Mossafa, Karine Courel, Jean-François Lesesve, Xavier Troussard

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Polyclonal B-cell lymphocytosis in English bulldogs.Journal of veterinary internal medicine · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Edouard CornetLaboratory of Hematology, Caen University Hospital, Caen, 14000, France. cornet-e@chu-caen.fr.
Hossein MossafaLaboratoire Cerba, Department of Genetic, Saint Ouen L'Aumone, 95310, France. hmossafa@lab-cerba.com.
Karine CourelLaboratoire Cerba, Department of Genetic, Saint Ouen L'Aumone, 95310, France. KCourel@lab-cerba.com.
Jean-François LesesveLaboratory of Hematology, Nancy University Hospital, Vandoeuvre-lès-Nancy Cedex, 54511, France. jf.lesesve@chu-nancy.fr.
Xavier TroussardLaboratory of Hematology, Caen University Hospital, Caen, 14000, France. troussard-x@chu-caen.fr.
Université de Caen Normandie · FRVirbac (France) · FRCentre Hospitalier Régional et Universitaire de Nancy · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersistent Polyclonal Binucleated B-cell Lymphocytosis (PPBL) is characterized by a chronic polyclonal B-cell lymphocytosis with binucleated lymphocytes and a polyclonal increase in serum immunoglobulin-M. Cytogenetic is characterized by the presence of a supernumerary isochromosome +i(3)(q10), premature chromosome condensation and chromosomal instability. Outcome of PPBL patients is mostly benign, but subsequent malignancies could occur. The aim of our study is to provide an update of clinical and cytogenetic characteristics of our large cohort of PPBL patients, to describe subsequent malignancies occurring during the follow-up, and to investigate the role of the long arm of chromosome 3 in PPBL.

resultsWe analyzed clinical, biological and cytogenetic characteristics (conventional cytogenetic analysis and fluorescent in situ hybridization) of 150 patients diagnosed with PPBL. We performed high-resolution SNP arrays in 10 PPBL patients, comparing CD19(+) versus CD19(-) lymphoid cells. We describe the cytogenetic characteristics in 150 PPBL patients consisting in the presence of supernumerary isochromosome +i(3)(q10) (59%) and chromosomal instability (55%). In CD19(+) B-cells, we observed recurrent copy number aberrations of 143 genes with 129 gains (90%) on 3q and a common minimal amplified genomic region in the MECOM gene. After a median follow-up of 60 months, we observed the occurrence of 12 subsequent malignancies (12%), 6 solid tumors and 6 Non-Hodgkin's Lymphomas, and 6 monoclonal gammopathies of undetermined significance (MGUS), requiring a long-term clinical follow-up.

conclusionsOur clinical and cytogenetic observations lead us to hypothesize that isochromosome 3q, especially MECOM abnormality, could play a key role in PPBL.

Indexed as

Chromosome AberrationsChromosomes, Human, Pair 3AdultAgedAntigens, CD19B-LymphocytesChromosomal InstabilityDNA-Binding ProteinsFemaleFollow-Up StudiesHematologic NeoplasmsHumansImmunoglobulin MIn Situ Hybridization, FluorescenceKaryotypingLymphocytosisAntigens, CD19DNA-Binding ProteinsImmunoglobulin MMDS1 and EVI1 Complex Locus ProteinMECOM protein, humanTranscription Factors

Identifiers

PMID26935937
PMCPMC4776409
OpenAlexW2289694743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.